SMAD3 and pulmonary fibrosis: Lack of SMAD3 in mice confers resistance to TGFβ, injury, or inflammation mediated renal and lung fibrosis [52], [53], [54] as well as chemical-induced liver and pancreatic fibrosis [55], [56].